SGMT (Sagimet Biosciences) FCF Margin %: 0.00% (As of Mar. 2026)


SGMT Sagimet Biosciences Inc SGMT
10 GF Score
Price $7.03
! 2 Warning Signs
View Full Analysis

What is Sagimet Biosciences FCF Margin %?

Sagimet Biosciences SGMT +1.59% 10 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates SGMT with a GF Score™ of 10/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Sagimet Biosciences ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sagimet Biosciences's Free Cash Flow for the three months ended in Mar. 2026 was $-8.61 Mil. Sagimet Biosciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Sagimet Biosciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Sagimet Biosciences's current FCF Yield % is -9.15%.

The historical rank and industry rank for Sagimet Biosciences's FCF Margin % or its related term are showing as below:


During the past 7 years, the highest FCF Margin % of Sagimet Biosciences was -1188.30%. The lowest was -1188.30%. And the median was -1188.30%.

SGMT's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Sagimet Biosciences FCF Margin % Related Terms

Sagimet Biosciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Sagimet Biosciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sagimet Biosciences FCF Margin % Chart

Sagimet Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -1,188.30 0.00 0.00

Sagimet Biosciences Quarterly Data
Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SGMT vs NGNE, UPB, STTK: FCF Margin % Comparison

For the Biotechnology subindustry, Sagimet Biosciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sagimet Biosciences FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sagimet Biosciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sagimet Biosciences's FCF Margin % falls into.


SGMT
10GF Score
Sagimet Biosciences Inc SGMT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sagimet Biosciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sagimet Biosciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-45.65/0
= %

Sagimet Biosciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-8.611/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Sagimet Biosciences (SGMT) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sagimet Biosciences and its competitors. According to the industry distribution chart, Sagimet Biosciences ranks #999999 out of 960 companies in the Biotechnology industry.
Is Sagimet Biosciences' FCF Margin % too high?
Sagimet Biosciences' current FCF Margin % is 0.00%. Based on the distribution chart, Sagimet Biosciences ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sagimet Biosciences has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Sagimet Biosciences' FCF Margin % compare to NGNE and UPB?
According to the Biotechnology industry distribution chart, Sagimet Biosciences ranks #999999 out of 960 companies for FCF Margin %. This places Sagimet Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sagimet Biosciences and its competitors. Sagimet Biosciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sagimet Biosciences stock overvalued right now?
Sagimet Biosciences (SGMT) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Sagimet Biosciences' overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sagimet Biosciences (SGMT), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sagimet Biosciences Business Description

Address 155 Bovet Road, Suite 303, San Mateo, CA, USA, 94402
Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.
10GF Score

Get the complete analysis for SGMT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.03
Price